Welcome to our dedicated page for Acco Brands SEC filings (Ticker: ACCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From Five Star notebooks that sync with a study app to Kensington laptop locks that safeguard data, ACCO Brands turns everyday work and learning into connected experiences across more than 100 countries. That reach produces detailed disclosures about segment margins, currency swings and seasonal inventory. If you’ve ever searched “where can I read the ACCO Brands quarterly earnings report 10-Q filing?” or “how do I track ACCO Brands insider trading Form 4 transactions?” and want “ACCO Brands SEC filings explained simply,” you’re in the right place.
Stock Titan’s AI digests every page the moment it hits EDGAR, translating jargon into plain-language highlights. Compare revenue trends with our “ACCO Brands earnings report filing analysis”, receive “ACCO Brands Form 4 insider transactions real-time” alerts, and see “ACCO Brands 8-K material events explained” before the market reacts. Need the big picture? The “ACCO Brands annual report 10-K simplified” view pinpoints cash-flow drivers, while proxy tools surface “ACCO Brands proxy statement executive compensation” tables in seconds. For deeper context, ask “understanding ACCO Brands SEC documents with AI” and follow linked excerpts back to the source paragraph.
Professionals use these insights to monitor “ACCO Brands executive stock transactions Form 4”, gauge back-to-school demand inside the 10-Q, and uncover supply-chain risks hidden in footnotes. Real-time notifications, historical archives and exportable tables let you model Americas versus International performance without combing through PDFs. Complex disclosures become clear, so you spend less time searching and more time deciding.
Form 4 filing – ACCO Brands Corporation (ACCO)
Senior Vice-President, General Counsel & Secretary Pamela R. Schneider disclosed two equity transactions executed on 18 June 2025.
- 1,354 Restricted Stock Units (RSUs) credited through dividend-equivalent provisions. Each unit converts into one common share on 14 Mar 2026.
- 1,261.7 RSUs granted under the company’s Incentive Plan, vesting on 12 Mar 2027.
Both transactions are coded “A” (acquisition) with an exercise price of $0, indicating awards rather than market purchases. Following these grants, Schneider directly holds 63,274.9 RSUs related to the 2026 tranche and 58,964.3 RSUs linked to the 2027 tranche, maintaining significant exposure to ACCO equity.
No shares were sold, and the filing contains no open-market activity, option exercises, or cash proceeds. The awards originate from the normal long-term incentive program, so share-count dilution is minimal. The document includes no earnings data, operational updates, or other financial metrics.
Overall, the filing modestly strengthens management-shareholder alignment but does not provide material insight into ACCO’s underlying performance or near-term outlook.
ACCO Brands Corporation (ACCO) – Form 4 insider filing
On 06/18/2025, Executive Vice-President and President ACCO Brands International, Patrick Buchenroth, reported the award of two blocks of restricted stock units (RSUs) under the company’s incentive plan. No open-market purchases or sales of common stock were disclosed.
- 1,598.4 RSUs granted; each unit converts to one common share on 03/14/2026 if service conditions are met.
- 1,927.6 RSUs granted; each unit converts to one common share on 03/12/2027 subject to continued employment.
The filing cites dividend-equivalent provisions as the source of the incremental RSUs. Both awards are recorded at a conversion/exercise price of $0, reflecting their nature as equity compensation rather than market transactions.
Following the grants, Buchenroth’s beneficial ownership of derivative securities (unvested RSUs) increased to 74,699.7 units for the 2026 tranche and 90,083.8 units for the 2027 tranche, all held directly. The Form 4 includes standard Rule 10b5-1 language and was signed by an attorney-in-fact on 06/20/2025.
No changes to direct common-stock holdings, cash compensation, or any sale/disposition were reported. The transaction is routine equity compensation intended to align executive incentives with shareholder interests, with no immediate cash flow or EPS impact.